Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Abcam pays $155mm for monoclonal antibody producer Epitomics

Executive Summary

Abcam PLC has acquired fellow antibody research tools company, privately held Epitomics Inc., for $155mm. Half of the sum will be paid in cash, with the rest in the form of approximately 14.7mm Abcam shares (based on the pre-announcement ten-day average of £3.34 ($5.29)).
Deal Industry
  • Contract Research, Toxicology Testing-CRO
  • In Vitro Diagnostics
  • Research, Analytical Equipment & Supplies
  • Services
  • Laboratory Testing Services
    • Anatomical Pathology
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Cash
    • Payment Includes Stock

Related Companies